Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O'Grady KE, Lee JD. Chandler RK, et al. Among authors: laska e. Contemp Clin Trials. 2016 May;48:166-72. doi: 10.1016/j.cct.2016.05.003. Epub 2016 May 11. Contemp Clin Trials. 2016. PMID: 27180088 Free PMC article. Clinical Trial.
Extended-release naltrexone opioid treatment at jail reentry (XOR).
McDonald RD, Tofighi B, Laska E, Goldfeld K, Bonilla W, Flannery M, Santana-Correa N, Johnson CW, Leibowitz N, Rotrosen J, Gourevitch MN, Lee JD. McDonald RD, et al. Among authors: laska e. Contemp Clin Trials. 2016 Jul;49:57-64. doi: 10.1016/j.cct.2016.05.002. Epub 2016 May 10. Contemp Clin Trials. 2016. PMID: 27178765 Free PMC article. Clinical Trial.
Corrigendum to "Extended-release naltrexone opioid treatment at jail reentry (XOR)" [Contemp. Clin. Trials 49 (2016) 57-64].
McDonald RD, Tofighi B, Laska E, Goldfeld K, Bonilla W, Flannery M, Santana-Correa N, Johnson CW, Leibowitz N, Rotrosen J, Gourevitch MN, Lee JD. McDonald RD, et al. Among authors: laska e. Contemp Clin Trials. 2016 Nov;51:96. doi: 10.1016/j.cct.2016.09.009. Epub 2016 Oct 13. Contemp Clin Trials. 2016. PMID: 27743800 No abstract available.
Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON).
Malone M, McDonald R, Vittitow A, Chen J, Obi R, Schatz D, Tofighi B, Garment A, Kermack A, Goldfeld K, Gold H, Laska E, Rotrosen J, Lee JD. Malone M, et al. Among authors: laska e. Contemp Clin Trials. 2019 Jun;81:102-109. doi: 10.1016/j.cct.2019.04.006. Epub 2019 Apr 12. Contemp Clin Trials. 2019. PMID: 30986535 Free PMC article. Clinical Trial.
Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool.
Adam A, Schwartz RP, Wu LT, Subramaniam G, Laska E, Sharma G, Mili S, McNeely J. Adam A, et al. Among authors: laska e. Addict Sci Clin Pract. 2019 Oct 15;14(1):39. doi: 10.1186/s13722-019-0167-z. Addict Sci Clin Pract. 2019. PMID: 31615549 Free PMC article. Clinical Trial.
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.
Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L. Bogenschutz MP, et al. Among authors: laska e. JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096. JAMA Psychiatry. 2022. PMID: 36001306 Free PMC article.
155 results